NCT03132974

Brief Summary

The Purpose of this trial is to investigate the efficacy and safety of herbal medicine with manipulation therapy on Korean Patients with Chronic Low Back Pain

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Sep 2018

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 19, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 28, 2017

Completed
1.3 years until next milestone

Study Start

First participant enrolled

September 1, 2018

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

March 30, 2021

Status Verified

March 1, 2021

Enrollment Period

3.3 years

First QC Date

April 19, 2017

Last Update Submit

March 27, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline in Numeric Rating Scale of Pain

    A 10-point Numerical Pain Rating Scale (NPRS; 0: no pain, 10: maximum pain) assesses the patients' current level of pain.

    Screening Visit, At baseline, week 2, 4, 6, 8

Secondary Outcomes (2)

  • Change from Baseline in 'Roland Morris Disability Questionnaire'

    Screening Visit, At baseline, week 2, 4, 6, 8

  • Change from Baseline in European Quality of life 5 Dimension

    Screening Visit, At baseline, week 2, 4, 6, 8

Other Outcomes (4)

  • Change from baseline in pelvic incidence

    At baseline, week 4, 8

  • Change from baseline in iliac crest height

    At baseline, week 4, 8

  • Change from baseline in lumbar gravity line

    At baseline, week 4, 8

  • +1 more other outcomes

Study Arms (3)

SGHH

EXPERIMENTAL

Admission to Sogyeonghwalhyeol-tang granule

Drug: Sogyeonghwalhyeol-tang granule

SGHH with manipulation therapy

EXPERIMENTAL

Admission to Sogyeonghwalhyeol-tang granule and manipulation therapy

Other: Sogyeonghwalhyeol-tang granule with manipulation procedure

Placebo with manipulation therapy

PLACEBO COMPARATOR
Other: Placebo with manipulation procedure

Interventions

Sogyeonghwalhyeol-tang herbal extract granule

SGHH

Sogyeonghwalhyeol-tang herbal extract granule with manipulation procedure

SGHH with manipulation therapy

Placebo granule with manipulation procedure

Placebo with manipulation therapy

Eligibility Criteria

Age19 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Inpatients with chief complaint of low back pain in oriental rehabilitation medical center
  • Age 19 - 65
  • Patients who have 4 \~7 cm of VAS pain score;
  • Ability to have normal communication
  • Ability to give informed consent

You may not qualify if:

  • Patients with pain duration of 3 months or less
  • Patients with progressive neurologic deficit or severe neurologic symptoms by SLR test
  • Patients diagnosed with serious pathology(s) which may cause low back pain (e.g. spinal metastasis of tumor(s), acute fracture, etc)
  • Patients with spondylolisthesis or spondylolysis(diagnosed with grade II or higher level)
  • Patients currently taking steroids, immunosuppressants, medicine for mental illness or other medication(s) that may interfere with study results
  • Patients with history of spinal surgery
  • Patients with more severe pain than pain caused by low back pain
  • Those who do not (cannot) abide by treatment and follow up due to the mental illness such as behavior disorder, depression, anxiety neurosis etc.
  • Patients with history of Medical Malpractice Case
  • Patients with treatment history of low back pain within 1 month either KM or WM
  • Patients participating in other clinical studies within 3 months
  • Pregnant patients or patients with plans of pregnancy or lactating patients
  • Patients disagree to sign the informed consent form
  • Patients deemed unsuitable for participating the trial by the researchers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gachon University Gil Oriental Medicine Hospital

Incheon, 22318, South Korea

RECRUITING

Related Publications (1)

  • Ko Y, Jang BH, Oh MS, Kim SJ, Ko YS, Ha IH, Lee EJ, Kim MR, Song YK, Ko SG. Evaluation of efficacy and safety of single and multiple therapy of herbal medicine/Chuna therapy on non-specific chronic low back pain: A study protocol for multicenter, 3-arm, randomized, single blinded, parallel group, incomplete factorial design, pilot study. Medicine (Baltimore). 2020 Jul 24;99(30):e21260. doi: 10.1097/MD.0000000000021260.

Study Officials

  • Yun-Kyung Song, PhD

    Gachon University Gil Oriental Medical Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Youme Ko, MA

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

April 19, 2017

First Posted

April 28, 2017

Study Start

September 1, 2018

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

March 30, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations